Heme Oxygenase-1 Induction by the Clinically Used Anesthetic Isoflurane Protects Rat Livers From Ischemia/Reperfusion Injury
Authors:
- Rene SchmidtRSRene Schmidt
- Eva TritschlerETEva Tritschler
- Alexander HoetzelAHAlexander Hoetzel
- Torsten LoopTLTorsten Loop
- Matjaz HumarMHMatjaz Humar
- Leonie HalverscheidLHLeonie Halverscheid
- Klaus K. GeigerKGKlaus K. Geiger
- Benedikt H. J. PannenBPBenedikt H. J. Pannen
- 1 June 2007
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 245 (6) , 931-942
Abstract
It was the aim of this study to characterize the influence of isoflurane-induced heme oxygenase-1 (HO-1) expression on hepatocellular integrity after ischemia and reperfusion. Abundant experimental data characterize HO-1 as one of the most powerful inducible enzymes that contribute to the protection of the liver and other organs after harmful stimuli. Therapeutic strategies aimed at utilizing the protective effects of HO-1 are hampered by the fact that most pharmacological inducers of this enzyme perturb organ function by themselves and are not available for use in patients because of their toxicity and undesirable or unknown side effects. Rats were pretreated with isoflurane before induction of partial hepatic ischemia (1 hour) and reperfusion (1 hour). At the end of each experiment, blood and liver tissue were obtained for molecular biologic, histologic, and immunohistochemical analyses. Isoflurane pretreatment increased hepatic HO-1 mRNA, HO-1 protein, HO enzyme activity, and decreased plasma levels of AST, ALT, and alpha-GST. Histologic analysis of livers obtained from isoflurane-pretreated rats showed a reduction of necrotic areas, particularly in the perivenular region, the predominant site of isoflurane-induced HO-1 expression. In addition, sinusoidal congestion that could otherwise be observed after ischemia/reperfusion was inhibited by the anesthetic. Furthermore, isoflurane augmented hepatic microvascular blood flow and lowered the malondialdehyde content within the liver compared with control animals. Administration of tin protoporphyrin IX inhibited HO activity and abolished the isoflurane-induced protective effects. This study provides first evidence that pretreatment with the nontoxic and clinically approved anesthetic isoflurane induces hepatic HO-1 expression, and thereby protects rat livers from ischemia/reperfusion injury.Keywords
This publication has 43 references indexed in Scilit:
- Heat Shock Proteins and Mitogen-activated Protein Kinases in Steatotic Livers Undergoing Ischemia-Reperfusion: Some AnswersThe American Journal of Pathology, 2006
- Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic ApplicationsPhysiological Reviews, 2006
- Effect of heat shock preconditioning on NF-κB/I-κB pathway during I/R injury of the rat liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathwayHepatology, 2002
- Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysisNature Medicine, 2001
- Hepatic ischemia-reperfusion injuryThe American Journal of Surgery, 2001
- Doxorubicin preconditioning: A protection against rat hepatic ischemia-reperfusion injuryHepatology, 2000
- Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryJournal of Clinical Investigation, 1999
- PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbitsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- Therapeutic approaches for ischemia/reperfusion injury in the liverJournal of Molecular Medicine, 1999